Sponsor Pipeline

Changchun Intellicrown Pharmaceutical Co. LTD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07016633 To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in… Metabolic Dysfunction-Associated Steatohepatitis (MASH) Not Yet Recruiting
Phase 1
NCT06216041 To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in… Nonalcoholic Steatohepatitis (NASH) Recruiting
NCT04412616 ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies Advanced EGFR Positive Solid Tumor Recruiting
Disease Areas
NASH / MASH (2)
Get alerts when Changchun Intellicrown Pharmaceutical Co. LTD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free